SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001213900-15-007443
Filing Date
2015-10-02
Accepted
2015-10-02 16:34:19
Documents
6
Effectiveness Date
2015-10-02

Document Format Files

Seq Description Document Type Size
1 REGISTRATION STATEMENTS fs82015_relmadatherape.htm S-8 599935
2 SPECIMEN COMMON STOCK CERTIFICATE fs82015ex4i_relmadatherape.htm EX-4.1 1293
3 OPINION OF FENNEMORE CRAIG, P.C. fs82015ex5i_relmadatherape.htm EX-5.1 19454
4 CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM fs82015ex23i_relmadatherape.htm EX-23.1 1905
5 GRAPHIC cert_1.jpg GRAPHIC 150900
6 GRAPHIC cert_2.jpg GRAPHIC 82015
  Complete submission text file 0001213900-15-007443.txt   944652
Mailing Address 546 FIFTH AVENUE, 14TH FLOOR NEW YORK NY 10036
Business Address 546 FIFTH AVENUE, 14TH FLOOR NEW YORK NY 10036 212-702-7163
RELMADA THERAPEUTICS, INC. (Filer) CIK: 0001553643 (see all company filings)

IRS No.: 455401931 | State of Incorp.: NV | Fiscal Year End: 0630
Type: S-8 | Act: 33 | File No.: 333-207253 | Film No.: 151140829
SIC: 2834 Pharmaceutical Preparations